The Net Margin of Egetis Therapeutics AB (publ) (EGTX.ST) is -745.12%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -745.12% |
2023-12-31 | -567.19% |
2022-12-31 | -857.52% |
2021-12-31 | -273.36% |
2020-12-31 | -437.81% |
2019-12-31 | -74.39% |
2018-12-31 | -301.31% |
2017-12-31 | -647.29% |